SIREN : 900643685
LAZEO MEDICAL METZ is a French company founded 4 years ago, specialized in the sector Location de terrains et d'autres biens immobiliers. Based in METZ (57070), this company of category ETI shows in 2023 a revenue of 913 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-09
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2023 |
|---|---|
| Revenue | 912 680 € |
| Net income | 54 939 € |
| EBITDA | 92 748 € |
| Net margin | 6.0% |
In 2023, LAZEO MEDICAL METZ achieves revenue of 913 k€. After deducting consumption (18 k€), gross margin stands at 894 k€, i.e. a rate of 98%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 93 k€, representing 10.2% of revenue. This level of operating margin is satisfactory for the sector. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 55 k€, i.e. 6.0% of revenue. This profit can be retained or distributed to shareholders.
912 680 €
894 189 €
92 748 €
56 655 €
54 939 €
10.2%
The debt ratio (= Financial debt / Equity x 100) stands at 0%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 24%. The balance between equity and debt is satisfactory. Cash flow represents 10.0% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment. Satisfactory level allowing partial financing of growth.
0.0%
23.83%
9.974%
0.0
69.4%
In 2023, the debt ratio of LAZEO MEDICAL METZ (0.00) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
In 2023, the financial autonomy of LAZEO MEDICAL METZ (23.8%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
In 2023, the repayment capacity of LAZEO MEDICAL METZ (0.00) ranks below the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. This controlled position reflects prudent management.
The liquidity ratio (= Current assets / Current liabilities) stands at 140.45. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
140.454
0.0
In 2023, the liquidity ratio of LAZEO MEDICAL METZ (140.45) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
In 2023, the interest coverage of LAZEO MEDICAL METZ (0.0x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 62 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 251 days. Excellent situation: suppliers finance 189 days of the operating cycle (retail model). Inventory turnover is 6 days (= Average inventory / Cost of goods x 360). Fast turnover, sign of good inventory management. Overall, WCR represents 175 days of revenue, i.e. 444 k€ to permanently finance.
444 074 €
62 j
251 j
6 j
175 j
Based on 215 transactions of similar company sales in 2023, the value of LAZEO MEDICAL METZ is estimated at 441 115 € (range 147 137€ - 824 460€). With an EBITDA of 92 748€, the sector multiple of 5.2x is applied. The price/revenue ratio is 0.51x (in line with sector norms). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Ajustez les pondérations selon votre analyse
This estimate is based on the analysis of 215 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare LAZEO MEDICAL METZ with other companies in the same sector:
Voir toutes les statistiques du secteur Location de terrains et d'autres biens immobiliers
The revenue of LAZEO MEDICAL METZ in 2023 is 913 k€.
Yes, LAZEO MEDICAL METZ generated a net profit of 55 k€ in 2023.
The headquarters of LAZEO MEDICAL METZ is located in METZ (57070), in the department Moselle.
The tax return of LAZEO MEDICAL METZ is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
LAZEO MEDICAL METZ operates in the sector Location de terrains et d'autres biens immobiliers (NAF code 68.20B). See the 'Sector positioning' section above to compare the company with its competitors.